Literature DB >> 22923335

Donor diabetes mellitus is an independent risk factor for graft loss in HCV positive but not HCV negative liver transplant recipients.

Ying Wu1, Aijaz Ahmed, Ahmad Kamal.   

Abstract

BACKGROUND AND AIMS: Graft survival in HCV (hepatitis C virus) infected recipients is worse than those transplanted for other liver diseases. We studied whether several donor cardiovascular risk factors (including advanced age, smoking, hypertension, and diabetes mellitus) contribute to worse outcomes for HCV positive and HCV negative liver transplant recipients.
METHODS: We obtained data from the United Network for Organ Sharing on all adult liver transplants performed in the United States between January 1, 1998 and December 31, 2003. In total, 27,033 transplant cases were evaluated. Independent predictors of graft survival were determined using Cox proportional hazards regression analysis after controlling for factors previously found to be associated with differences in transplant outcomes.
RESULTS: Donor diabetes was a strong independent risk factor for graft failure [hazard ratio (HR) = 1.20, p = 0.006] only in HCV positive recipients. Neither donor smoking status nor hypertension predicted graft loss in either cohort. Consistent with previous studies, advanced donor age, donation after cardiac death, height, and African American donor all predicted graft loss amongst both cohorts.
CONCLUSION: Accounting for donor diabetes in relation to recipient HCV status in the selection of liver recipients may result in improved graft survival.

Entities:  

Mesh:

Year:  2012        PMID: 22923335      PMCID: PMC3670815          DOI: 10.1007/s10620-012-2345-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

Review 1.  When is steatosis too much for transplantation?

Authors:  Antonio Nocito; Ashraf Mohammad El-Badry; Pierre-Alain Clavien
Journal:  J Hepatol       Date:  2006-07-31       Impact factor: 25.083

2.  The association between hepatitis C infection and survival after orthotopic liver transplantation.

Authors:  Lisa M Forman; James D Lewis; Jesse A Berlin; Harold I Feldman; Michael R Lucey
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

3.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

Review 4.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Endocr Rev       Date:  2002-10       Impact factor: 19.871

Review 5.  Non-alcoholic fatty liver disease: an overview.

Authors:  Brian P Mulhall; Janus P Ong; Zobair M Younossi
Journal:  J Gastroenterol Hepatol       Date:  2002-11       Impact factor: 4.029

Review 6.  Hepatitis C virus and liver transplantation.

Authors:  Elizabeth C Verna; Robert S Brown
Journal:  Clin Liver Dis       Date:  2006-11       Impact factor: 6.126

7.  Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients.

Authors:  G Paolisso; A D'Amore; C Volpe; V Balbi; F Saccomanno; D Galzerano; D Giugliano; M Varricchio; F D'Onofrio
Journal:  Metabolism       Date:  1994-11       Impact factor: 8.694

Review 8.  Risk of extended criteria donors in hepatitis C virus-positive recipients.

Authors:  Marina Berenguer
Journal:  Liver Transpl       Date:  2008-10       Impact factor: 5.799

9.  Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.

Authors:  Anna Kotronen; Leena Juurinen; Mirja Tiikkainen; Satu Vehkavaara; Hannele Yki-Järvinen
Journal:  Gastroenterology       Date:  2008-03-21       Impact factor: 22.682

10.  Contribution of marginal donors to liver transplantation for hepatitis C virus infection.

Authors:  J Briceño; R Ciria; M Pleguezuelo; A Naranjo; J Sánchez-Hidalgo; J Ruiz-Rabelo; P López-Cillero; A Luque; M de la Mata; S Rufián
Journal:  Transplant Proc       Date:  2007-09       Impact factor: 1.066

View more
  5 in total

1.  Key donor factors associated with graft loss among liver transplant recipients with human immunodeficiency virus.

Authors:  Isabel Campos-Varela; Jennifer L Dodge; Peter G Stock; Norah A Terrault
Journal:  Clin Transplant       Date:  2016-08-03       Impact factor: 2.863

2.  The corrected donor age for hepatitis C virus-infected liver transplant recipients.

Authors:  Melisa Dirchwolf; Jennifer L Dodge; Jane Gralla; Kiran M Bambha; Trevor Nydam; Kenneth W Hung; Hugo R Rosen; Sandy Feng; Norah A Terrault; Scott W Biggins
Journal:  Liver Transpl       Date:  2015-08       Impact factor: 5.799

Review 3.  Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.

Authors:  Jérôme Dumortier; Olivier Boillot; Jean-Yves Scoazec
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

4.  Donor Diabetes and Prolonged Cold Ischemia Time Synergistically Increase the Risk of Graft Failure After Liver Transplantation.

Authors:  Isabel M A Brüggenwirth; Natasha H Dolgin; Robert J Porte; Adel Bozorgzadeh; Paulo N A Martins
Journal:  Transplant Direct       Date:  2017-06-12

5.  Donor diabetes mellitus is a risk factor for diminished outcome after liver transplantation: a nationwide retrospective cohort study.

Authors:  Isabel M A Brüggenwirth; Marjolein van Reeven; Indrė Vasiliauskaitė; Danny van der Helm; Bart van Hoek; Alexander F Schaapherder; Ian P J Alwayn; Aad P van den Berg; Vincent E de Meijer; Sarwa Darwish Murad; Wojciech G Polak; Robert J Porte
Journal:  Transpl Int       Date:  2020-11-05       Impact factor: 3.782

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.